Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Transdifferentiation of Human Circulating Monocytes Into Neuronal-Like Cells in 20 Days and Without Reprograming.

Bellon A, Wegener A, Lescallette AR, Valente M, Yang SK, Gardette R, Matricon J, Mouaffak F, Watts P, Vimeux L, Yun JK, Kawasawa YI, Clawson GA, Blandin E, Chaumette B, Jay TM, Krebs MO, Feuillet V, Hosmalin A.

Front Mol Neurosci. 2018 Sep 19;11:323. doi: 10.3389/fnmol.2018.00323. eCollection 2018.

2.

Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages.

Linton SS, Abraham T, Liao J, Clawson GA, Butler PJ, Fox T, Kester M, Matters GL.

PLoS One. 2018 Nov 1;13(11):e0206759. doi: 10.1371/journal.pone.0206759. eCollection 2018.

3.

"Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma.

Clawson GA, Matters GL, Xin P, McGovern C, Wafula E, dePamphilis C, Meckley M, Wong J, Stewart L, D'Jamoos C, Altman N, Imamura Kawasawa Y, Du Z, Honaas L, Abraham T.

PLoS One. 2017 Sep 28;12(9):e0184451. doi: 10.1371/journal.pone.0184451. eCollection 2017.

4.

Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancer.

Loc WS, Linton SS, Wilczynski ZR, Matters GL, McGovern CO, Abraham T, Fox T, Gigliotti CM, Tang X, Tabakovic A, Martin JA, Clawson GA, Smith JP, Butler PJ, Kester M, Adair JH.

Nanomedicine. 2017 Oct;13(7):2313-2324. doi: 10.1016/j.nano.2017.06.017. Epub 2017 Jul 1.

5.

A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma.

Clawson GA, Abraham T, Pan W, Tang X, Linton SS, McGovern CO, Loc WS, Smith JP, Butler PJ, Kester M, Adair JH, Matters GL.

Nucleic Acid Ther. 2017 Feb;27(1):23-35. doi: 10.1089/nat.2016.0621. Epub 2016 Oct 18.

6.

Histone deacetylase inhibitors as cancer therapeutics.

Clawson GA.

Ann Transl Med. 2016 Aug;4(15):287. doi: 10.21037/atm.2016.07.22.

7.

Macrophage-tumor cell fusions from peripheral blood of melanoma patients.

Clawson GA, Matters GL, Xin P, Imamura-Kawasawa Y, Du Z, Thiboutot DM, Helm KF, Neves RI, Abraham T.

PLoS One. 2015 Aug 12;10(8):e0134320. doi: 10.1371/journal.pone.0134320. eCollection 2015.

8.

Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.

Kaifi JT, Kunkel M, Das A, Harouaka RA, Dicker DT, Li G, Zhu J, Clawson GA, Yang Z, Reed MF, Gusani NJ, Kimchi ET, Staveley-O'Carroll KF, Zheng SY, El-Deiry WS.

Cancer Biol Ther. 2015;16(5):699-708. doi: 10.1080/15384047.2015.1030556.

9.

Cancer. Fusion for moving.

Clawson GA.

Science. 2013 Nov 8;342(6159):699-700. doi: 10.1126/science.1244270. No abstract available.

PMID:
24202164
10.

Vagus nerve regulates breast cancer metastasis to the adrenal gland.

Erin N, Barkan GA, Clawson GA.

Anticancer Res. 2013 Sep;33(9):3675-82.

PMID:
24023295
11.

Biorecognition by DNA oligonucleotides after exposure to photoresists and resist removers.

Dean SL, Morrow TJ, Patrick S, Li M, Clawson GA, Mayer TS, Keating CD.

Langmuir. 2013 Sep 10;29(36):11535-45. doi: 10.1021/la402362u. Epub 2013 Aug 29.

12.
13.

Circulating tumor cells in melanoma patients.

Clawson GA, Kimchi E, Patrick SD, Xin P, Harouaka R, Zheng S, Berg A, Schell T, Staveley-O'Carroll KF, Neves RI, Mosca PJ, Thiboutot D.

PLoS One. 2012;7(7):e41052. doi: 10.1371/journal.pone.0041052. Epub 2012 Jul 19.

14.

Down-regulation of HtrA1 activates the epithelial-mesenchymal transition and ATM DNA damage response pathways.

Wang N, Eckert KA, Zomorrodi AR, Xin P, Pan W, Shearer DA, Weisz J, Maranus CD, Clawson GA.

PLoS One. 2012;7(6):e39446. doi: 10.1371/journal.pone.0039446. Epub 2012 Jun 26.

15.

Identification of mammary epithelial cells subject to chronic oxidative stress in mammary epithelium of young women and teenagers living in USA: implication for breast carcinogenesis.

Weisz J, Shearer DA, Murata E, Patrick SD, Han B, Berg A, Clawson GA.

Cancer Biol Ther. 2012 Jan 15;13(2):101-13. doi: 10.4161/cbt.13.2.18873. Epub 2012 Jan 15.

16.

Nanoresonator chip-based RNA sensor strategy for detection of circulating tumor cells: response using PCA3 as a prostate cancer marker.

Sioss JA, Bhiladvala RB, Pan W, Li M, Patrick S, Xin P, Dean SL, Keating CD, Mayer TS, Clawson GA.

Nanomedicine. 2012 Aug;8(6):1017-25. doi: 10.1016/j.nano.2011.11.009. Epub 2011 Nov 22.

17.

Primer-free aptamer selection using a random DNA library.

Pan W, Clawson GA.

Methods Mol Biol. 2010;629:369-85. doi: 10.1007/978-1-60761-657-3_24.

PMID:
20387162
18.

MicroRNAs align with accessible sites in target mRNAs.

Pan W, Xin P, Clawson GA.

J Cell Biochem. 2010 Feb 15;109(3):509-18. doi: 10.1002/jcb.22428.

19.
20.

The shorter the better: reducing fixed primer regions of oligonucleotide libraries for aptamer selection.

Pan W, Clawson GA.

Molecules. 2009 Mar 27;14(4):1353-69. doi: 10.3390/molecules14041353. Review.

21.

An RNA Sensor Platform for CTC Detection: Nanotechnology for Detection of Tumour Cell Marker RNAs.

Clawson GA, Keating C, Bhiladvala R, Pan W, Mayer T.

Bioforum Eur. 2009 Feb;13(1-2):10-11.

22.

Altered gene expression in breast cancer liver metastases.

Erin N, Wang N, Xin P, Bui V, Weisz J, Barkan GA, Zhao W, Shearer D, Clawson GA.

Int J Cancer. 2009 Apr 1;124(7):1503-16. doi: 10.1002/ijc.24131.

23.

Catalytic DNAzymes: derivations and functions.

Pan W, Clawson GA.

Expert Opin Biol Ther. 2008 Aug;8(8):1071-85. doi: 10.1517/14712598.8.8.1071 . Review.

PMID:
18613760
24.

Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level.

Erin N, Akdas Barkan G, Harms JF, Clawson GA.

Regul Pept. 2008 Nov 29;151(1-3):35-42. doi: 10.1016/j.regpep.2008.03.012. Epub 2008 Apr 3.

PMID:
18499282
25.

Intracellular localization of the tumor suppressor HtrA1/Prss11 and its association with HPV16 E6 and E7 proteins.

Clawson GA, Bui V, Xin P, Wang N, Pan W.

J Cell Biochem. 2008 Sep 1;105(1):81-8. doi: 10.1002/jcb.21804.

PMID:
18452160
26.

Minimal primer and primer-free SELEX protocols for selection of aptamers from random DNA libraries.

Pan W, Xin P, Clawson GA.

Biotechniques. 2008 Mar;44(3):351-60. doi: 10.2144/000112689.

27.

IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway.

Smith TM, Gilliland K, Clawson GA, Thiboutot D.

J Invest Dermatol. 2008 May;128(5):1286-93. Epub 2007 Nov 8.

28.

Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth.

Yang J, Pan WH, Clawson GA, Richmond A.

Cancer Res. 2007 Apr 1;67(7):3127-34.

29.

Identifying accessible sites in RNA: the first step in designing antisense reagents.

Pan WH, Clawson GA.

Curr Med Chem. 2006;13(25):3083-103. Review.

PMID:
17073649
30.

The chloromethylketone protease inhibitor AAPF(CMK) also targets ATP-dependent helicases and SAP-domain proteins.

Dhamne C, Drubin DA, Duncan K, Tevethia MJ, Clawson GA.

J Cell Biochem. 2007 Feb 15;100(3):716-26.

PMID:
17006953
31.

Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1.

Smith TM, Cong Z, Gilliland KL, Clawson GA, Thiboutot DM.

J Invest Dermatol. 2006 Jun;126(6):1226-32.

32.

A protease inhibitor specifically inhibits growth of HPV-infected keratinocytes.

Drubin DA, McLaughlin-Drubin ME, Clawson GA, Meyers C.

Mol Ther. 2006 Jun;13(6):1142-8. Epub 2006 Mar 27.

33.

Antisense applications for biological control.

Pan WH, Clawson GA.

J Cell Biochem. 2006 May 1;98(1):14-35. Review.

PMID:
16440307
34.

Comparison of cryopreservation and standard needle biopsy for gene expression profiling of human breast cancer specimens.

Drubin D, Smith JS, Liu W, Zhao W, Chase GA, Clawson GA.

Breast Cancer Res Treat. 2005 Mar;90(1):93-6.

PMID:
15770532
35.

Parameters affecting substance P measurement in heart, lung, and skin.

Erin N, Clawson GA.

Biotechniques. 2004 Aug;37(2):232, 234, 236 passim.

36.
37.

Inhibition of papilloma progression by antisense oligonucleotides targeted to HPV11 E6/E7 RNA.

Clawson GA, Miranda GQ, Sivarajah A, Xin P, Pan W, Thiboutot D, Christensen ND.

Gene Ther. 2004 Sep;11(17):1331-41.

PMID:
15229628
38.

Capsaicin-mediated denervation of sensory neurons promotes mammary tumor metastasis to lung and heart.

Erin N, Boyer PJ, Bonneau RH, Clawson GA, Welch DR.

Anticancer Res. 2004 Mar-Apr;24(2B):1003-9.

39.
40.

Identification of efficient cleavage sites in long-target RNAs.

Pan WH, Clawson GA.

Methods Mol Biol. 2004;252:125-44.

PMID:
15017046
41.
42.

Involvement of the fungal nuclear migration gene nudC human homolog in cell proliferation and mitotic spindle formation.

Zhang MY, Huang NN, Clawson GA, Osmani SA, Pan W, Xin P, Razzaque MS, Miller BA.

Exp Cell Res. 2002 Feb 1;273(1):73-84.

PMID:
11795948
43.

A selection system for identifying accessible sites in target RNAs.

Pan WH, Devlin HF, Kelley C, Isom HC, Clawson GA.

RNA. 2001 Apr;7(4):610-21.

44.

Genomic instability-based transgenic models of prostate cancer.

Voelkel-Johnson C, Voeks DJ, Greenberg NM, Barrios R, Maggouta F, Kurtz DT, Schwartz DA, Keller GM, Papenbrock T, Clawson GA, Norris JS.

Carcinogenesis. 2000 Aug;21(8):1623-7.

PMID:
10910968
45.

Nuclear localization of catechol-O-methyltransferase in neoplastic and nonneoplastic mammary epithelial cells.

Weisz J, Fritz-Wolz G, Gestl S, Clawson GA, Creveling CR, Liehr JG, Dabbs D.

Am J Pathol. 2000 Jun;156(6):1841-8.

46.

Growth inhibition by a triple ribozyme targeted to repetitive B2 transcripts.

Crone TM, Schalles SL, Benedict CM, Pan W, Ren L, Loy SE, Isom H, Clawson GA.

Hepatology. 1999 Apr;29(4):1114-23.

PMID:
10094955
47.

Induction of nuclear catechol-O-methyltransferase by estrogens in hamster kidney: implications for estrogen-induced renal cancer.

Weisz J, Fritz-Wolz G, Clawson GA, Benedict CM, Abendroth C, Creveling CR.

Carcinogenesis. 1998 Jul;19(7):1307-12.

PMID:
9683193
48.

Triple ribozyme-mediated down-regulation of the retinoblastoma gene.

Benedict CM, Pan W, Loy SE, Clawson GA.

Carcinogenesis. 1998 Jul;19(7):1223-30.

PMID:
9683181
49.

Biogenesis and inactivation of catecholestrogens.

Weisz J, Clawson GA, Creveling CR.

Adv Pharmacol. 1998;42:828-33. No abstract available.

PMID:
9328025
50.

Expression of SCL is normal in transfusion-dependent Diamond-Blackfan anemia but other bHLH proteins are deficient.

Zhang MY, Clawson GA, Olivieri NF, Bell LL, Begley CG, Miller BA.

Blood. 1997 Sep 1;90(5):2068-74.

PMID:
9292545

Supplemental Content

Loading ...
Support Center